Evidence map›Paper›PMID 25140878›Full record

ArticlePloS one2014

Elevated heart rate triggers action potential alternans and sudden death. translational study of a homozygous KCNH2 mutation.

Ulrich Schweigmann, Peter Biliczki, Rafael J Ramirez, Christoph Marschall, Ina Takac, Ralf P Brandes, Dieter Kotzot, Zenawit Girmatsion, Stefan H Hohnloser, Joachim R Ehrlich

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ulrich SchweigmannPediatric Cardiology, Innsbruck Medical University, Innsbruck, Austria.
Peter BiliczkiDivision of Clinical Electrophysiology, Goethe University, Frankfurt, Germany; Div. of Cardiology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
Rafael J RamirezCenter for Arrhythmia Research, University of Michigan, Ann Arbor, Michigan, United States of America.
Christoph MarschallLaboratory for Human Genetics, Martinsried, Germany.
Ina TakacInstitute of Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Ralf P BrandesInstitute of Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Dieter KotzotSection for Human Genetics, Innsbruck Medical University, Innsbruck, Austria.
Zenawit GirmatsionDivision of Clinical Electrophysiology, Goethe University, Frankfurt, Germany.
Stefan H HohnloserDivision of Clinical Electrophysiology, Goethe University, Frankfurt, Germany.
Joachim R EhrlichDivision of Clinical Electrophysiology, Goethe University, Frankfurt, Germany; Div. of Cardiology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany.

Funding

Inhibition of chloride secretion by cigarette smokeK08HL081080 · NHLBI · CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS · PI KREINDLER, JAMES LEVIN · 2006 to 2010
$655k
NHLBI NIH HHS K08 HL081080
6 · The paper itself

Abstract

backgroundLong QT syndrome (LQTS) leads to arrhythmic events and increased risk for sudden cardiac death (SCD). Homozygous KCNH2 mutations underlying LQTS-2 have previously been termed "human HERG knockout" and typically express severe phenotypes. We studied genotype-phenotype correlations of an LQTS type 2 mutation identified in the homozygous index patient from a consanguineous Turkish family after his brother died suddenly during febrile illness. METHODS AND

resultsClinical work-up, DNA sequencing, mutagenesis, cell culture, patch-clamp, in silico mathematical modelling, protein biochemistry, confocal microscopy were performed. Genetic analysis revealed a homozygous C-terminal KCNH2 mutation (p.R835Q) in the index patient (QTc ∼506 ms with notched T waves). Parents were I° cousins - both heterozygous for the mutation and clinically unremarkable (QTc ∼447 ms, father and ∼396 ms, mother). Heterologous expression of KCNH2-R835Q showed mildly reduced current amplitudes. Biophysical properties of ionic currents were also only nominally changed with slight acceleration of deactivation and more negative V50 in R835Q-currents. Protein biochemistry and confocal microscopy revealed similar expression patterns and trafficking of WT and R835Q, even at elevated temperature. In silico analysis demonstrated mildly prolonged ventricular action potential duration (APD) compared to WT at a cycle length of 1000 ms. At a cycle length of 350 ms M-cell APD remained stable in WT, but displayed APD alternans in R835Q.

conclusionKv11.1 channels affected by the C-terminal R835Q mutation display mildly modified biophysical properties, but leads to M-cell APD alternans with elevated heart rate and could precipitate SCD under specific clinical circumstances associated with high heart rates.

Indexed as

MutationAction PotentialsChildChild, PreschoolDeath, Sudden, CardiacDNA Mutational AnalysisERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsFamilyHeart RateHumansLong QT SyndromeMaleERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsKCNH2 protein, human

Identifiers

PMID25140878
PMCPMC4139196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.